Having trouble viewing this email? View in your browser..

AstraZeneca logo. Heading: Join us for the AstraZeneca Integrated Session at ECCMID 2021. Subheading: ECCMID 2021 - 31st European Congress of Clinical Microbiology & Infectious Diseases
Deciphering the data:
Clinical impact of vaccines and monoclonal antibodies for COVID-19

Friday 9 July 16:15–18:15 CEST (15:15–17:15 BST)
This AstraZeneca-sponsored integrated session aims to provide an update on the global collaborative effort to tackle the COVID-19 pandemic through research into vaccines and therapeutics.

Featuring global expert speakers, the session will provide an overview of potential prevention and treatment strategies to target the SARS-CoV-2 virus, with a focus on the latest clinical data and what it means in the real world.

Professor Tobias Welte | Hannover University School of Medicine
Dr Ashleigh Tuite | University of Toronto; ESCMID-appointed Chair
Abstract illustration
16:30–16:50 | COVID-19 vaccines: current and future outlooks

Professor Kirsty Le Doare
(St George's, University of London) will discuss the current status of COVID-19 vaccines, and what the future holds for vaccine development.
Abstract illustration
17:00–17:20 | Monoclonal antibody therapies for COVID-19: applications and implications

Professor Hugh Montgomery
(University College London) will describe the development and usage of monoclonal antibodies and the role these will play in the prevention and treatment of COVID-19.
Abstract illustration
17:30–17:50 | Life in the changing pandemic landscape

Professor Barbara Rath
(Vienna Vaccine Safety Initiative) will provide a person-centric view of ongoing and future changes as a result of the COVID-19 pandemic.
Following each presentation there will be a 10 minute live Q&A with the speaker and Chairs.
We welcome you to explore AstraZeneca’s commitment to advancing COVID-19 prevention and treatment.

© AstraZeneca 2021

Veeva ID: CH-4079; Date of preparation: May 2021
AstraZeneca logo

You have received this email as a contact of ESCMID or one of its affiliated societies.
You can unsubscribe or change your newsletter subscriptions here.